{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:20:16Z","timestamp":1789539616637,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T00:00:00Z","timestamp":1522627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3057-1","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T22:37:52Z","timestamp":1522795072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: a qualitative study"],"prefix":"10.1186","volume":"18","author":[{"name":"on behalf of the TAP study group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9302-2430","authenticated-orcid":false,"given":"Stelliana","family":"Goutzamanis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Dietze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Hellard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Higgs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,2]]},"reference":[{"key":"3057_CR1","unstructured":"World Health Organisation. Global hepatitis report 2017. Geneva; 2017. Report No.: CC BY-NC-SA 3.0 IGO"},{"key":"3057_CR2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5694\/j.1326-5377.1995.tb139937.x","volume":"162","author":"SI Strasser","year":"1995","unstructured":"Strasser SI, Watson KJ, Lee CS, Coghlan PJ, Desmond PV. Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection. Med J Aust. 1995;162:355\u20138.","journal-title":"Med J Aust"},{"key":"3057_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S1386-6532(02)00116-6","volume":"26","author":"GJ Dore","year":"2003","unstructured":"Dore GJ, Law M, MacDonald M, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol. 2003;26:171\u201384.","journal-title":"J Clin Virol"},{"key":"3057_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7150\/ijms.3.47","volume":"3","author":"SL Chen","year":"2006","unstructured":"Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3:47\u201352.","journal-title":"Int J Med Sci"},{"key":"3057_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/1874220301603010052","volume":"3","author":"M Chin","year":"2016","unstructured":"Chin M, Hogan C, Nguyen D. The natural history of hepatitis C viral infection: clinical evaluation and monitoring. Open Med. 2016;3:52\u20137.","journal-title":"Open Med"},{"key":"3057_CR6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","volume":"10","author":"B Hajarizadeh","year":"2013","unstructured":"Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 2013;10:553\u201362.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3057_CR7","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","volume":"61","author":"RH Westbrook","year":"2014","unstructured":"Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol. 2014;61:S58\u201368.","journal-title":"J Hepatol"},{"key":"3057_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.5694\/mja16.00106","volume":"204","author":"AJ Thompson","year":"2016","unstructured":"Thompson AJ. Australian recommendations for the management of hepatitis C virus infection: a consensus statement. Med J Aust. 2016;204:268\u201372.","journal-title":"Med J Aust"},{"issue":"12","key":"3057_CR9","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","volume":"29","author":"L Sandrin","year":"2003","unstructured":"Sandrin L, Fourquet B, Hasquenoph J-M, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705\u201313.","journal-title":"Ultrasound Med Biol"},{"key":"3057_CR10","volume-title":"EASL recommendations on treatment of hepatitis C 2016","author":"European Association for the Study of the Liver","year":"2016","unstructured":"European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2016. Switzerland: European Association for the Study of the Liver; 2016."},{"key":"3057_CR11","volume-title":"Australian Reccomendations for the management of hepatitis C virus infection: a consensus statement (January 2017)","author":"Hepatitis C Virus Infection Consensus Statement Working Group","year":"2017","unstructured":"Hepatitis C Virus Infection Consensus Statement Working Group. Australian Reccomendations for the management of hepatitis C virus infection: a consensus statement (January 2017). Melbourne: Gastroenterological Society of Australia; 2017."},{"key":"3057_CR12","volume-title":"Combating hepatitis B and C to reach elimination by 2030","author":"World Health Organisation","year":"2016","unstructured":"World Health Organisation. Combating hepatitis B and C to reach elimination by 2030. Geneva: World Health Organisation; 2016. http:\/\/apps.who.int\/iris\/bitstream\/10665\/206453\/1\/WHO_HIV_2016.04_eng.pdf?ua=1 . Accessed 4 June 2017."},{"key":"3057_CR13","doi-asserted-by":"publisher","unstructured":"Scott N, McBryde ES, Thompson A, Doyle JS, Hellard ME. Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model. Gut. Published Online First: 12 April 2016. https:\/\/doi.org\/10.1136\/gutjnl-2016-311504 .","DOI":"10.1136\/gutjnl-2016-311504"},{"key":"3057_CR14","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/j.1467-9566.2009.01172.x","volume":"31","author":"M Harris","year":"2009","unstructured":"Harris M. Troubling biographical disruption: narratives of unconcern about hepatitis C diagnosis. Sociol Helath Illn. 2009;31:1028\u201342.","journal-title":"Sociol Helath Illn"},{"key":"3057_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1300\/J013v39n04_07","volume":"39","author":"B Crockett","year":"2004","unstructured":"Crockett B, Gifford SM. \u201cEyes wide shut\u201d: narratives of women living with hepatitis C in Australia. Women Health. 2004;39:117\u201337.","journal-title":"Women Health"},{"key":"3057_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0020-7489(00)00046-8","volume":"38","author":"M Glacken","year":"2001","unstructured":"Glacken M, Kernohan G, Coates V. Diagnosed with hepatitis C: a descriptive exploratory study. Int J Nurs Stud. 2001;38:107\u201316.","journal-title":"Int J Nurs Stud"},{"key":"3057_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1080\/1465989031000109770","volume":"8","author":"B Faye","year":"2003","unstructured":"Faye B, Irurita V. Balancing perspective: the response to feelings of being condemned with the hepatitis C virus. J Subst Use. 2003;8:92\u2013103.","journal-title":"J Subst Use"},{"key":"3057_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/1467-9566.ep11339939","volume":"4","author":"M Bury","year":"1982","unstructured":"Bury M. Chronic illness as biographical disruption. Sociol Health Illn. 1982;4:167\u201382.","journal-title":"Sociol Health Illn"},{"key":"3057_CR19","volume-title":"Handbook of stress, coping, and health: implications for nursing research, theory, and practice","author":"VH Rice","year":"2000","unstructured":"Rice VH. Handbook of stress, coping, and health: implications for nursing research, theory, and practice. Thousand Oaks: SAGE Publications Inc; 2000."},{"key":"3057_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/00006199-198109000-00002","volume":"30","author":"MH Mishel","year":"1981","unstructured":"Mishel MH. The measurement of uncertainty in illness. Nurs Res. 1981;30:258\u201363.","journal-title":"Nurs Res"},{"key":"3057_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1547-5069.1988.tb00082.x","volume":"20","author":"MH Mishel","year":"1988","unstructured":"Mishel MH. Uncertainty in illness. Image J Nurs Sch. 1988;20:225\u201332.","journal-title":"Image J Nurs Sch"},{"key":"3057_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1037\/0090-5550.46.4.363","volume":"46","author":"NEJ Sanders-Dewey","year":"2001","unstructured":"Sanders-Dewey NEJ, Mullins LL, Chaney JM. Coping style, perceived uncertainty in illness, and distress in individuals with Parkinson's disease and their caregivers. Rehabil Psychol. 2001;46:363\u201381.","journal-title":"Rehabil Psychol"},{"key":"3057_CR23","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/0277-9536(85)90436-8","volume":"21","author":"C Mason","year":"1985","unstructured":"Mason C. The production and effects of uncertainty with special reference to diabetes mellitus. Soc Sci Med. 1985;21:1329\u201334.","journal-title":"Soc Sci Med"},{"key":"3057_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11764-012-0229-7","volume":"6","author":"LE Miller","year":"2012","unstructured":"Miller LE. Sources of uncertainty in cancer survivorship. J Cancer Surviv. 2012;6:431\u201340.","journal-title":"J Cancer Surviv"},{"key":"3057_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1055-3290(98)80078-2","volume":"9","author":"D Brashers","year":"1998","unstructured":"Brashers D, Neidig J, Reynolds N, Haas S. Uncertainty in illness across the HIV\/AIDS trajectory. J Assoc Nurses AIDS Care. 1998;9:66\u201377.","journal-title":"J Assoc Nurses AIDS Care"},{"key":"3057_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1477-7525-6-76","volume":"6","author":"KK O\u2019Brien","year":"2008","unstructured":"O\u2019Brien KK, Bayoumi AM, Strike C, Young NL, Davis AM. Exploring disability from the perspective of adults living with HIV\/AIDS: development of a conceptual framework. Helath Qual Life Out. 2008;6:76.","journal-title":"Helath Qual Life Out"},{"issue":"2","key":"3057_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1176\/appi.psy.50.2.138","volume":"50","author":"DE Bailey","year":"2009","unstructured":"Bailey DE, Landerman L, Barroso J, Bixby P, Mishel MH, Muir AJ, et al. Uncertainty, symptoms and quality of life in persons with chronic hepatitis C undergoing watchful waiting. Psychosomatics. 2009;50(2):138\u201346.","journal-title":"Psychosomatics"},{"issue":"5","key":"3057_CR28","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1360-0443.2004.00692.x","volume":"99","author":"T Rhodes","year":"2004","unstructured":"Rhodes T, Davis M, Judd A. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. Addiction. 2004;99(5):621\u201333.","journal-title":"Addiction"},{"key":"3057_CR29","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.drugpo.2015.05.006","volume":"26","author":"M Hellard","year":"2015","unstructured":"Hellard M, McBryde E, Davis RS, Rolls DA, Higgs P, Aitken C, et al. Hepatitis C transmission and treatment as prevention - the role of the injecting network. Int J Drug Policy. 2015;26:958\u201362.","journal-title":"Int J Drug Policy"},{"key":"3057_CR30","volume-title":"Qualitative research methods","author":"P Liamputtong","year":"2005","unstructured":"Liamputtong P, Ezzy D. Qualitative research methods. 2nd ed. Oxford: Oxford University Press; 2005.","edition":"2"},{"key":"3057_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1136\/bmj.311.6996.42","volume":"311","author":"C Pope","year":"1995","unstructured":"Pope C, Mays N. Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ. 1995;311:42\u20135.","journal-title":"BMJ"},{"key":"3057_CR32","first-page":"121","volume":"2","author":"S Conrad","year":"2006","unstructured":"Conrad S, Garrett LE, Cooksley WG, Dunne MP, MacDonald GA. Living with chronic hepatitis C means \u2018you just haven\u2019t got a normal life any more\u2019. Chronic Illn. 2006;2:121\u201331.","journal-title":"Chronic Illn"},{"key":"3057_CR33","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1177\/1049732309341656","volume":"19","author":"C Treloar","year":"2009","unstructured":"Treloar C, Rhodes T. The lived experience of hepatitis C and its treatment among injecting drug users: qualitative synthesis. Qual Health Res. 2009;19:1321\u201334.","journal-title":"Qual Health Res"},{"key":"3057_CR34","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3109\/09687637.2014.970516","volume":"22","author":"K Lancaster","year":"2015","unstructured":"Lancaster K, Santana L, Madden A, Ritter A. Stigma and subjectivities: examining the textured relationship between lived experience and opinions about drug policy among people who inject drugs. Drugs Educ Prev Policy. 2015;22:224\u201331.","journal-title":"Drugs Educ Prev Policy"},{"key":"3057_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/0193945907302771","volume":"30","author":"G Butt","year":"2008","unstructured":"Butt G, Paterson BL, McGuinness LK. Living with the stigma of hepatitis C. West J Nurs Res. 2008;30:204\u201323.","journal-title":"West J Nurs Res"},{"key":"3057_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-2458-7-98","volume":"7","author":"F-M Khaw","year":"2007","unstructured":"Khaw F-M, Stobbart L, Murtagh MJ. \u2018I just keep thinking I haven\u2019t got it because I\u2019m not yellow\u2019: a qualitative study of the factors that influence the uptake of hepatitis C testing by prisoners. BMC Public Health. 2007;7:98.","journal-title":"BMC Public Health"},{"key":"3057_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/apc.2006.0206","volume":"22","author":"MA Lally","year":"2008","unstructured":"Lally MA, Montstream-Quas SA, Tanaka S, Tedeschi SK, Morrow KM. A qualitative study among injection drug using women in Rhode Island: attitudes toward testing, treatment, and vaccination for hepatitis and HIV. AIDS Patient Care ST. 2008;22:53\u201364.","journal-title":"AIDS Patient Care ST"},{"key":"3057_CR38","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1465-3362.2012.00468.x","volume":"31","author":"C Treloar","year":"2012","unstructured":"Treloar C, Hull P, Dore GJ, Grebely J. Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs. Drug Alcohol Rev. 2012;31:918\u201324.","journal-title":"Drug Alcohol Rev"},{"key":"3057_CR39","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0275-4959(00)80032-0","volume-title":"Health, illness, and use of care: the impact of social factors","author":"A Royer","year":"2000","unstructured":"Royer A. Uncertainty: a key characteristic of chronic illness and a major problem for managed care. In: Kronenfeld J, editor. Health, illness, and use of care: the impact of social factors. United Kingdom: Emerald Group Publishing Limited; 2000. p. 269\u201386."},{"key":"3057_CR40","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1080\/00365520902898135","volume":"44","author":"E Bj\u00f6rnsson","year":"2009","unstructured":"Bj\u00f6rnsson E, Verbaan H, Oksanen A, Fryd\u00e9n A, Johansson J, Friberg S, et al. Health-related quality of life in patients with different stages of liver disease induced by hepatitis C. Scan J Gastroenterol. 2009;44:878\u201387.","journal-title":"Scan J Gastroenterol"},{"key":"3057_CR41","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jhep.2006.10.009","volume":"46","author":"HL Bonkovsky","year":"2007","unstructured":"Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana RJ, Sterling RK, et al. Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis. J Hepatol. 2007;46:420\u201331.","journal-title":"J Hepatol"},{"key":"3057_CR42","volume-title":"Hep C treatment stories 2015","author":"Hepatitis Australia","year":"2017","unstructured":"Hepatitis Australia. Hep C treatment stories 2015. 2017. http:\/\/www.hepatitisaustralia.com\/speakoutstories\/ . Accessed 4 June 2017."},{"key":"3057_CR43","unstructured":"Bager T, Jensen N, \u00d8vrehus A, PB. C, Nielsen D, editors. \u201cI got my life back!\u201d- Patients\u2019 experiences on being cured for hepatitis C: a qualitative study of fatigue and everyday life in a group of danish patients. 5th International Symposium on Hepatitis Care in Substance Users; 2016; Oslo."},{"key":"3057_CR44","unstructured":"Hepatitis Victoria. Personal Stories 2017. 2017 http:\/\/www.hepvic.org.au\/page\/1172\/personal-stories . Accessed 4 June 2017."},{"issue":"2","key":"3057_CR45","doi-asserted-by":"publisher","first-page":"S817","DOI":"10.1016\/S0168-8278(16)01598-1","volume":"64","author":"S von Bibra","year":"2016","unstructured":"von Bibra S, Doyle JS, Higgs P, Dietze P, Desmond P, Stoove M, et al. Feasibiliy of recruiting people who inject drugs into a nurse-led model of care trial: the tap study. J Hepatol. 2016;64(2):S817\u2013S8.","journal-title":"J Hepatol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3057-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3057-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3057-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T21:27:50Z","timestamp":1571002070000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3057-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3057"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3057-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,2]]},"assertion":[{"value":"4 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All TAP participants provided informed written consent and extra informed verbal consent to participate in the qualitative interview. Ethics approval was received by the Monash University Human Research Ethics Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Participants provided informed consent for publications of findings.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"J Doyle has received research funding from Gilead Sciences, GSK and Abbvie Inc. A Thompson has served as a consultant for Gilead Sciences, Merck & Co, Abbvie Inc., Bristol-Myers Squibb and Roche Diagnostics, a speaker for Bristol-Myers Squibb and has received research funding from Gilead Sciences, Abbvie Inc., Merck & Co and Bristol-Myers Squibb. P Dietze has received research funding from Gilead Sciences and Reckitt Benckiser. M Hellard has received investigator initiated research funding from Gilead Sciences, GSK and Abbvie Inc. P Higgs has received research funding from Gilead Sciences.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"151"}}